These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 28525404)

  • 1. Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence.
    Grimberg A; Allen DB
    Curr Opin Pediatr; 2017 Aug; 29(4):466-471. PubMed ID: 28525404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency.
    Grimberg A; DiVall SA; Polychronakos C; Allen DB; Cohen LE; Quintos JB; Rossi WC; Feudtner C; Murad MH;
    Horm Res Paediatr; 2016; 86(6):361-397. PubMed ID: 27884013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement.
    Kennedy MJ; Davis DA; Smith N; Gaedigk A; Pearce RE; Kearns GL
    Clin Ther; 2008 Sep; 30(9):1687-99. PubMed ID: 18840375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone, enhancement and the pharmaceuticalisation of short stature.
    Morrison M
    Soc Sci Med; 2015 Apr; 131():305-12. PubMed ID: 25455477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S; Salerno M; Garofalo P; Cardinale GM; Licenziati MR; Citro G; Caruso Nicoletti M; Cappa M; Longobardi S; Maghnie M; Perrone R
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in the definition and treatment of idiopathic short stature (ISS).
    Pedicelli S; Peschiaroli E; Violi E; Cianfarani S
    J Clin Res Pediatr Endocrinol; 2009; 1(3):105-15. PubMed ID: 21274395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic response of subscapular skinfold thickness to hGH or IGF-1 administration to patients with congenital IGHD, congenital MPHD and Laron syndrome.
    Bisker-Kassif O; Kauli R; Lilos P; Laron Z
    Obes Res Clin Pract; 2014; 8(1):e55-62. PubMed ID: 24548577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles of growth hormone and insulin-like growth factor-I treatment in children with idiopathic short stature.
    Bang P
    Horm Res Paediatr; 2011; 76 Suppl 3():24-6. PubMed ID: 21912155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of growth-promoting therapy.
    Rosenfeld RG
    Growth Horm IGF Res; 2016 Jun; 28():43-5. PubMed ID: 26654694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL; Lee PA; Gut R; Germak J
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract]   [Full Text] [Related]  

  • 13. Current practice in diagnosis and treatment of growth hormone deficiency in childhood: a survey from Turkey.
    Poyrazoğlu Ş; Akçay T; Arslanoğlu İ; Atabek ME; Atay Z; Berberoğlu M; Bereket A; Bideci A; Bircan İ; Böber E; Can Ş; Cesur Y; Darcan Ş; Demir K; Dündar B; Ersoy B; Esen İ; Güven A; Kara C; Keskin M; Kurtoğlu S; Memioğlu N; Özbek MN; Özgen T; Sarı E; Şıklar Z; Şimşek E; Turan S; Yeşilkaya E; Yüksel B; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):37-44. PubMed ID: 25800474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chairman's summary: Therapeutic options for the treatment of children with idiopathic short stature.
    Dahlgren J
    Horm Res Paediatr; 2011; 76 Suppl 3():23. PubMed ID: 21912154
    [No Abstract]   [Full Text] [Related]  

  • 15. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
    Pfäffle R
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and diagnostic approach to children of low stature. Evaluation of a 24-month hGH treatment of patients with growth impairment of diverse etiopathogenesis].
    Azzaroli L; Zucchini A; Manfredi R; Demaria F; Manfredi G
    Pediatr Med Chir; 1992; 14(3):279-83. PubMed ID: 1528795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of hGH and IGF-I on body proportions.
    Laron Z; Silbergeld A; Kauli R
    Anthropol Anz; 2012 Jul; 69(3):255-9. PubMed ID: 22928349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists.
    Hardin DS; Woo J; Butsch R; Huett B
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):85-94. PubMed ID: 17201806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Conscious Growth-Promoting Treatment: When Discretion Is the Better Part of Value.
    Allen DB
    Horm Res Paediatr; 2018; 90(3):145-150. PubMed ID: 30269127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.